{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:43:49Z","timestamp":1746535429476},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T00:00:00Z","timestamp":1509753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ijwd.2017.11.001","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:02:20Z","timestamp":1518177740000},"page":"131-138","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effects of autoimmune blistering diseases on work productivity: A review"],"prefix":"10.1097","volume":"4","author":[{"given":"Esther Q.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Adriana","family":"Castrill\u00f3n Vel\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"10.1016\/j.ijwd.2017.11.001_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2310\/7750.2009.08068","article-title":"Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis","volume":"13","author":"Chan","year":"2009","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.ijwd.2017.11.001_bb0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.det.2011.03.009","article-title":"Pemphigus and quality of life","volume":"29","author":"Chee","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ijwd.2017.11.001_bb9000","article-title":"Chinese version of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire: Reliability and validity","author":"Chen","year":"2017","journal-title":"Indian J Derm VL"},{"key":"10.1016\/j.ijwd.2017.11.001_bb0015","first-page":"708908","article-title":"Estimating the impact of workplace bullying: humanistic and economic burden among workers with chronic medical conditions","author":"Fattori","year":"2015","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.001_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1346-8138.2011.01382.x","article-title":"Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires","volume":"39","author":"Ghodsi","year":"2012","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2017.11.001_bb0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1203475415582317","article-title":"Loss of work productivity and quality of life in patients with autoimmune bullous dermatoses","volume":"19","author":"Heelan","year":"2015","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.ijwd.2017.11.001_bb0030","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.001_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.advms.2016.07.002","article-title":"Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease-specific Autoimmune Bullous Disease Quality of Life (ABQoL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQoL) questionnaires","volume":"62","author":"Kalinska-Bienias","year":"2017","journal-title":"Adv Med Sci"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.001_bb0040","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jaad.2010.10.020","article-title":"The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis","volume":"66","author":"Kimball","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.ijwd.2017.11.001_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D32110028943","article-title":"Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity","volume":"21","author":"Korman","year":"2015","journal-title":"Dermatol Online J"},{"issue":"9","key":"10.1016\/j.ijwd.2017.11.001_bb0050","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1468-3083.2010.03600.x","article-title":"Psoriasis: an epidemiological evaluation of disease burden in 590 patients","volume":"24","author":"Meyer","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2017.11.001_bb0055","series-title":"Blistering diseases: clinical features, pathogenesis, treatment","author":"Murrell","year":"2015"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.001_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2008.09.014","article-title":"Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools","volume":"60","author":"Paradisi","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.001_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/abd1806-4841.20153372","article-title":"Quality of life index in autoimmune bullous dermatosis patients","volume":"90","author":"Penha","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2017.11.001_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00019053-200422040-00002","article-title":"A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective","volume":"22","author":"Prasad","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.001_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/mjd.2003.128","article-title":"Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis","volume":"48","author":"Reilly","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.001_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.ijwd.2017.11.001_bb0085","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/bjd.13848","article-title":"Health-related quality of life and its determinants in pemphigus: a systematic review and meta-analysis","volume":"173","author":"Rencz","year":"2015","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.ijwd.2017.11.001_bb0090","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/jid.2009.72","article-title":"Reliability and convergent validity of two outcome instruments for pemphigus","volume":"129","author":"Rosenbach","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.001_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00403-015-1567-x","article-title":"Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis","volume":"307","author":"Schmitt","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.ijwd.2017.11.001_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.det.2011.11.008","article-title":"Quality-of-life measurement in blistering diseases","volume":"30","author":"Sebaratnam","year":"2012","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.ijwd.2017.11.001_bb0105","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamadermatol.2013.4972","article-title":"Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire","volume":"149","author":"Sebaratnam","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.001_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clindermatol.2011.03.016","article-title":"Quality of life in patients with bullous dermatoses","volume":"30","author":"Sebaratnam","year":"2012","journal-title":"Clin Dermatol"},{"issue":"9","key":"10.1016\/j.ijwd.2017.11.001_bb0115","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s11136-015-0965-z","article-title":"Reliability of the autoimmune bullous disease quality of life (ABQoL) questionnaire in the USA","volume":"24","author":"Sebaratnam","year":"2015","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.ijwd.2017.11.001_bb0120","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/bjd.12000","article-title":"Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial","volume":"167","author":"Strober","year":"2012","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.001_bb0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2133.2008.08481.x","article-title":"The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire","volume":"158","author":"Tabolli","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.001_bb0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bjd.12836","article-title":"Burden of disease during quiescent periods in patients with pemphigus","volume":"170","author":"Tabolli","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.001_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40273-014-0209-z","article-title":"Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence","volume":"33","author":"Tang","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.001_bb0140","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/bjd.12623","article-title":"The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease","volume":"169","author":"Tjokrowidjaja","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2017.11.001_bb0145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF03261868","article-title":"Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting","volume":"10","author":"Vender","year":"2012","journal-title":"Appl Health Econ Health Policy"},{"issue":"10","key":"10.1016\/j.ijwd.2017.11.001_bb0150","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","article-title":"Position paper from the World Health Organization","volume":"41","author":"World Health Organization Quality of Life Assessment (WHOQoL)","year":"1995","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.ijwd.2017.11.001_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12955-017-0594-z","article-title":"Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQoL) questionnaire","volume":"15","author":"Yang","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"10.1016\/j.ijwd.2017.11.001_bb0160","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/1346-8138.12220","article-title":"Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis","volume":"40","author":"Yano","year":"2013","journal-title":"J Dermatol"},{"issue":"9","key":"10.1016\/j.ijwd.2017.11.001_bb0165","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3899\/jrheum.100123","article-title":"Canadian Arthritis Network Work Productivity Group. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments","volume":"37","author":"Zhang","year":"2010","journal-title":"J Rheumatol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647517300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647517300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T02:54:31Z","timestamp":1719802471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647517300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2352647517300928"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2017.11.001","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of autoimmune blistering diseases on work productivity: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}